Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 18, 2023
Single-cell RNA sequencing reveals peripheral blood mononuclear immune cell landscape associated with operational tolerance in a kidney transplant recipientShafquat Azim, Haseeb Zubair, Thomas Rousselle, et al.
Kidney International|March 2, 2023
Single nuclei transcriptomics delineates complex immune and kidney cell interactions contributing to kidney allograft fibrosisJennifer M McDaniels, Amol C Shetty, Cem Kuscu, et al.
Biorxiv : the Preprint Server for Biology|January 8, 2024
Exogenous mitochondrial transfer increases energy expenditure and attenuates adiposity gains in mice with diet-induced obesityMaria Namwanje, Soumi Mazumdar, Amanda Stayton, et al.
International Journal of Molecular Sciences|June 2, 2021
Rapamycin Alternatively Modifies Mitochondrial Dynamics in Dendritic Cells to Reduce Kidney Ischemic Reperfusion InjuryMaria Namwanje, Bijay Bisunke, Thomas V Rousselle, et al.
Cancer Research|May 16, 2015
miR-181a-5p Inhibits Cancer Cell Migration and Angiogenesis via Downregulation of Matrix Metalloproteinase-14Yiyi Li, Cem Kuscu, Anna Banach, et al.
Oncotarget|May 27, 2015
Hypoxia promotes colon cancer dissemination through up-regulation of cell migration-inducing protein (CEMIP)Nikki A Evensen, Yiyi Li, Cem Kuscu, et al.
Biorxiv : the Preprint Server for Biology|October 31, 2023
Unveiling APOL1 Haplotypes: A Novel Classification Through Probe-Independent Quantitative Real-Time PCRMurat Dogan, Christine Watkins, Holly Ingram, et al.
Frontiers in Medicine|April 25, 2024
Unveiling APOL1 haplotypes in a predominantly African-American cohort of kidney transplant patients: a novel classification using probe-independent quantitative real-time PCRMurat Dogan, Christine Watkins, Holly Ingram, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 24, 2020
Targeted CRISPR screening identifies PRMT5 as synthetic lethality combinatorial target with gemcitabine in pancreatic cancer cellsXiaolong Wei, Jiekun Yang, Sara J Adair, et al.
Nature Communications|October 17, 2018
CRISPR knockout screening identifies combinatorial drug targets in pancreatic cancer and models cellular drug responseKarol Szlachta, Cem Kuscu, Turan Tufan, et al.
Pageof 5